Status:
UNKNOWN
PSA Glycomics Assay for Early Detection of Prostate Cancer
Lead Sponsor:
Prof.dr. H.P. Beerlage
Collaborating Sponsors:
Amsterdam UMC, location VUmc
The Netherlands Cancer Institute
Conditions:
Prostate Cancer
PSA
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The principal aim of this pilot study is to test whether the PSA Glycomics Assay on urine and serum samples can provide insights regarding the disease state of patients with elevated PSA concentration...
Eligibility Criteria
Inclusion
- Patients with elevated PSA (\>3 ng/mL)
- Signed informed consent
Exclusion
- Patients that have a cystitis (bladder infection)
- Patients under chemotherapy
- Patients using 5-alpha reductase inhibitors
- History or presence of cancers, or non-prostate urological disorders.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04393376
Start Date
August 1 2020
End Date
August 1 2025
Last Update
September 26 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands, 1105 AZ
2
Amsterdam UMC, location VUmc
Amsterdam, Netherlands
3
Leiden University Medical Centre
Leiden, Netherlands